Detalles de la búsqueda
1.
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(7): 1915-1925, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079070
2.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Support Care Cancer
; 31(6): 350, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227523
3.
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
Support Care Cancer
; 30(1): 585-591, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347181
4.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Ann Hematol
; 99(2): 331-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853703
5.
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Transfus Apher Sci
; 59(6): 102911, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859502
6.
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts.
Biol Blood Marrow Transplant
; 25(8): 1586-1591, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002994
7.
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Biol Blood Marrow Transplant
; 24(3): 608-613, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032271
8.
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after highdose melphalan and autologous stem cell transplantation.
Ann Hematol
; 102(8): 2297-2298, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347271
9.
Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.
Biol Blood Marrow Transplant
; 23(7): 1215-1220, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28344060
10.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26458240
11.
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
Biol Blood Marrow Transplant
; 21(5): 881-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636377
12.
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
Cytotherapy
; 17(10): 1485-93, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26188967
13.
Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.
Transfusion
; 55(8): 2032-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25857853
14.
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
Transfusion
; 54(8): 2028-33, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24588265
15.
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.
Blood Transfus
; 21(6): 514-525, 2023 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146295
16.
Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Expert Opin Biol Ther
; 22(3): 407-421, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463175
17.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Cancers (Basel)
; 13(11)2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34072068
18.
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
Expert Rev Hematol
; 12(8): 665-684, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251688
19.
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
Front Immunol
; 15: 1384002, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756776
20.
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
Bone Marrow Transplant
; 53(4): 461-473, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29330395